{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:55:36Z","timestamp":1793663736764,"version":"4.5.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Genetic diseases have been historically segregated into rare Mendelian disorders and common complex conditions. Large-scale studies using genome sequencing are eroding this distinction and are gradually unmasking the underlying complexity of human traits. Here, we analysed data from the Genomics England 100,000 Genomes Project and from a cohort of 1313 individuals with albinism aiming to gain insights into the genetic architecture of this archetypal rare disorder. We investigated the contribution of protein-coding and regulatory variants both rare and common. We focused on\n                    <jats:italic>TYR<\/jats:italic>\n                    , the gene encoding tyrosinase, and found that a high-frequency promoter variant,\n                    <jats:italic>TYR<\/jats:italic>\n                    c.\u2212301C&gt;T [rs4547091], modulates the penetrance of a prevalent, albinism-associated missense change,\n                    <jats:italic>TYR<\/jats:italic>\n                    c.1205G&gt;A (p.Arg402Gln) [rs1126809]. We also found that homozygosity for a haplotype formed by three common, functionally-relevant variants,\n                    <jats:italic>TYR<\/jats:italic>\n                    c.[\u2212301C;575C&gt;A;1205G&gt;A], is associated with a high probability of receiving an albinism diagnosis (OR&gt;82). This genotype is also associated with reduced visual acuity and with increased central retinal thickness in UK Biobank participants. Finally, we report how the combined analysis of rare and common variants can increase diagnostic yield and can help inform genetic counselling in families with albinism.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31392-3","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T04:13:55Z","timestamp":1657253635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-392X","authenticated-orcid":false,"given":"Vincent","family":"Michaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalie","family":"Lasseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-7213","authenticated-orcid":false,"given":"Dave T.","family":"Gerrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Plaisant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UK Biobank Eye and Vision Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2370-8496","authenticated-orcid":false,"given":"Tomas","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8314-8497","authenticated-orcid":false,"given":"Ewan","family":"Birney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-2932","authenticated-orcid":false,"given":"Beno\u00eet","family":"Arveiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-6592","authenticated-orcid":false,"given":"Graeme C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-4123","authenticated-orcid":false,"given":"Panagiotis I.","family":"Sergouniotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"31392_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","volume":"577","author":"M Claussnitzer","year":"2020","unstructured":"Claussnitzer, M. et al. A brief history of human disease genetics. Nature 577, 179\u2013189 (2020).","journal-title":"Nature"},{"key":"31392_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2019.02.003","volume":"177","author":"J Shendure","year":"2019","unstructured":"Shendure, J., Findlay, G. M. & Snyder, M. W. Genomic medicine\u2013progress, pitfalls, and promise. Cell 177, 45\u201357 (2019).","journal-title":"Cell"},{"key":"31392_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ajhg.2017.04.003","volume":"100","author":"KM Boycott","year":"2017","unstructured":"Boycott, K. M. et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am. J. Hum. Genet. 100, 695 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"31392_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ajmg.a.61124","volume":"179","author":"CR Ferreira","year":"2019","unstructured":"Ferreira, C. R. The burden of rare diseases. Am. J. Med. Genet. 179, 885\u2013892 (2019).","journal-title":"Am. J. Med. Genet."},{"key":"31392_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajmg.a.62463","volume":"185","author":"A Chakravarti","year":"2021","unstructured":"Chakravarti, A. Magnitude of Mendelian versus complex inheritance of rare disorders. Am. J. Med. Genet. 185, 1\u20137 (2021).","journal-title":"Am. J. Med. Genet"},{"key":"31392_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"31392_CR7","doi-asserted-by":"publisher","unstructured":"Caulfield, M. et al. The National Genomic Research Library. https:\/\/doi.org\/10.6084\/m9.figshare.4530893.v7 (2017).","DOI":"10.6084\/m9.figshare.4530893.v7"},{"key":"31392_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","volume":"562","author":"MEK Niemi","year":"2018","unstructured":"Niemi, M. E. K. et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature 562, 268\u2013271 (2018).","journal-title":"Nature"},{"key":"31392_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1056\/NEJMoa1706594","volume":"380","author":"JM Tilghman","year":"2019","unstructured":"Tilghman, J. M. et al. Molecular genetic anatomy and risk profile of Hirschsprung\u2019s disease. N. Engl. J. Med. 380, 1421\u20131432 (2019).","journal-title":"N. Engl. J. Med."},{"key":"31392_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41586-020-2434-2","volume":"583","author":"E Turro","year":"2020","unstructured":"Turro, E. et al. Whole-genome sequencing of patients with rare diseases in a national health system. Nature 583, 96 (2020).","journal-title":"Nature"},{"key":"31392_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41525-021-00176-x","volume":"6","author":"BHY Chung","year":"2021","unstructured":"Chung, B. H. Y., Chau, J. F. T. & Wong, G. K.-S. Rare versus common diseases: a false dichotomy in precision medicine. NPJ Genom. Med. 6, 19 (2021).","journal-title":"NPJ Genom. Med"},{"key":"31392_CR12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41436-020-0787-4","volume":"22","author":"M Khan","year":"2020","unstructured":"Khan, M. et al. Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics. Genet. Med. 22, 1235\u20131246 (2020).","journal-title":"Genet. Med."},{"key":"31392_CR13","first-page":"135","volume":"53","author":"AR Harper","year":"2021","unstructured":"Harper, A. R. et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat. Genet. 2021 532 53, 135\u2013142 (2021).","journal-title":"Nat. Genet. 2021 532"},{"key":"31392_CR14","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.ophtha.2018.08.003","volume":"125","author":"CC Kruijt","year":"2018","unstructured":"Kruijt, C. C. et al. The phenotypic spectrum of albinism. Ophthalmology 125, 1953\u20131960 (2018).","journal-title":"Ophthalmology"},{"key":"31392_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1126\/science.17.419.75.a","volume":"17","author":"WC Farabee","year":"1903","unstructured":"Farabee, W. C. Notes on Negro albinism. Science 17, 75 (1903).","journal-title":"Science"},{"key":"31392_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0140-6736(01)78482-6","volume":"172","author":"AE Garrod","year":"1908","unstructured":"Garrod, A. E. The Croonian lectures on inborn errors of metabolism. Lancet 172, 1\u20137 (1908).","journal-title":"Lancet"},{"key":"31392_CR17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/pcmr.12688","volume":"31","author":"E Lasseaux","year":"2018","unstructured":"Lasseaux, E. et al. Molecular characterization of a series of 990 index patients with albinism. Pigment Cell Melanoma Res. 31, 466\u2013474 (2018).","journal-title":"Pigment Cell Melanoma Res."},{"key":"31392_CR18","first-page":"725","volume":"37","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Spectrum of pathological genetic variants among 405 Chinese pedigrees affected with oculocutaneous albinism. Chin. J. Med. Genet 37, 725\u2013730 (2020).","journal-title":"Chin. J. Med. Genet"},{"key":"31392_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/jhg.2016.123","volume":"62","author":"L Mauri","year":"2017","unstructured":"Mauri, L. et al. Clinical evaluation and molecular screening of a large consecutive series of albino patients. J. Hum. Genet. 62, 277\u2013290 (2017).","journal-title":"J. Hum. Genet."},{"key":"31392_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-genom-083118-015230","volume":"20","author":"WJ Pavan","year":"2019","unstructured":"Pavan, W. J. & Sturm, R. A. The genetics of human skin and hair pigmentation. Annu. Rev. Genom. Hum. Genet. 20, 41\u201372 (2019).","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"31392_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51768-8","volume":"9","author":"P Campbell","year":"2019","unstructured":"Campbell, P. et al. Clinical and genetic variability in children with partial albinism. Sci. Rep. 9, 16576 (2019).","journal-title":"Sci. Rep."},{"key":"31392_CR22","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"31392_CR23","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005 (2019).","journal-title":"Nucleic Acids Res."},{"key":"31392_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/pcmr.12546","volume":"30","author":"MB Dolinska","year":"2017","unstructured":"Dolinska, M. B. et al. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity. Pigment Cell Melanoma Res. 30, 41 (2017).","journal-title":"Pigment Cell Melanoma Res."},{"key":"31392_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/jid.2010.274","volume":"131","author":"M Chaki","year":"2011","unstructured":"Chaki, M. et al. Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients. J. Investig. Dermatol. 131, 260\u2013262 (2011).","journal-title":"J. Investig. Dermatol."},{"key":"31392_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/pcmr.12253","volume":"27","author":"K Jagirdar","year":"2014","unstructured":"Jagirdar, K. et al. Molecular analysis of common polymorphisms within the human Tyrosinase locus and genetic association with pigmentation traits. Pigment Cell Melanoma Res. 27, 552\u2013564 (2014).","journal-title":"Pigment Cell Melanoma Res."},{"key":"31392_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/bjophthalmol-2018-312729","volume":"103","author":"S Monferm\u00e9","year":"2019","unstructured":"Monferm\u00e9, S. et al. Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene. Br. J. Ophthalmol. 103, 1239\u20131247 (2019).","journal-title":"Br. J. Ophthalmol."},{"key":"31392_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"31392_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"The ENCODE Project Consortium.","year":"2020","unstructured":"The ENCODE Project Consortium. et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583, 699\u2013710 (2020).","journal-title":"Nature"},{"key":"31392_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s42003-019-0430-6","volume":"2","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Genetic analyses of human fetal retinal pigment epithelium gene expression suggest ocular disease mechanisms. Commun. Biol. 2, 186 (2019).","journal-title":"Commun. Biol."},{"key":"31392_CR31","first-page":"38","volume":"18","author":"M Reinisalo","year":"2012","unstructured":"Reinisalo, M., Putula, J., Mannermaa, E., Urtti, A. & Honkakoski, P. Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site. Mol. Vis. 18, 38\u201354 (2012).","journal-title":"Mol. Vis."},{"key":"31392_CR32","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze, G. & Schemper, M. A solution to the problem of separation in logistic regression. Stat. Med. 21, 2409\u20132419 (2002).","journal-title":"Stat. Med."},{"key":"31392_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth, D. Bias reduction of maximum likelihood estimates. Biometrika 80, 27 (1993).","journal-title":"Biometrika"},{"key":"31392_CR34","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41588-018-0192-y","volume":"50","author":"SE Castel","year":"2018","unstructured":"Castel, S. E. et al. Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat. Genet. 50, 1327\u20131334 (2018).","journal-title":"Nat. Genet."},{"key":"31392_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"31392_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37272-5","volume":"9","author":"K Gr\u00f8nskov","year":"2019","unstructured":"Gr\u00f8nskov, K. et al. A pathogenic haplotype, common in Europeans, causes autosomal recessive albinism and uncovers missing heritability in OCA1. Sci. Rep. 9, 1\u20137 (2019).","journal-title":"Sci. Rep."},{"key":"31392_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51768-8","volume":"9","author":"P Campbell","year":"2019","unstructured":"Campbell, P. et al. Clinical and genetic variability in children with partial albinism. Sci. Rep. 9, 1\u201310 (2019).","journal-title":"Sci. Rep."},{"key":"31392_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41525-021-00275-9","volume":"7","author":"S Lin","year":"2022","unstructured":"Lin, S. et al. Evidence that the Ser192Tyr\/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B). NPJ Genom. Med. 7, 2 (2022).","journal-title":"NPJ Genom. Med"},{"key":"31392_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/ejn.14396","volume":"49","author":"C Mason","year":"2019","unstructured":"Mason, C. & Guillery, R. Conversations with Ray Guillery on albinism: linking Siamese cat visual pathway connectivity to mouse retinal development. Eur. J. Neurosci. 49, 913\u2013927 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"31392_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson, P. D. et al. The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum. Genet. 139, 1197\u20131207 (2020).","journal-title":"Hum. Genet."},{"key":"31392_CR41","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ng1333","volume":"36","author":"ML Freedman","year":"2004","unstructured":"Freedman, M. L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388\u2013393 (2004).","journal-title":"Nat. Genet."},{"key":"31392_CR42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.0006-341X.1999.00997.x","volume":"55","author":"B Devlin","year":"1999","unstructured":"Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997\u20131004 (1999).","journal-title":"Biometrics"},{"key":"31392_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/gepi.20379","volume":"33","author":"T Dadd","year":"2009","unstructured":"Dadd, T., Weale, M. E. & Lewis, C. M. A critical evaluation of genomic control methods for genetic association studies. Genet. Epidemiol. 33, 290\u2013298 (2009).","journal-title":"Genet. Epidemiol."},{"key":"31392_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013423 (2015).","journal-title":"Genet. Med."},{"key":"31392_CR45","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1136\/bmj.k1687","volume":"361","author":"C Turnbull","year":"2018","unstructured":"Turnbull, C. et al. The 100,000 Genomes Project: bringing whole genome sequencing to the NHS. BMJ 361, 1687 (2018).","journal-title":"BMJ"},{"key":"31392_CR46","doi-asserted-by":"publisher","first-page":"D1207","DOI":"10.1093\/nar\/gkaa1043","volume":"49","author":"S K\u00f6hler","year":"2021","unstructured":"K\u00f6hler, S. et al. The human phenotype ontology in 2021. Nucleic Acids Res. 49, D1207\u2013D1217 (2021).","journal-title":"Nucleic Acids Res."},{"key":"31392_CR47","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/bioinformatics\/btt314","volume":"29","author":"C Raczy","year":"2013","unstructured":"Raczy, C. et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics 29, 2041\u20132043 (2013).","journal-title":"Bioinformatics"},{"key":"31392_CR48","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/bioinformatics\/btv112","volume":"31","author":"A Tan","year":"2015","unstructured":"Tan, A., Abecasis, G. R. & Kang, H. M. Unified representation of genetic variants. Bioinformatics 31, 2202\u20132204 (2015).","journal-title":"Bioinformatics"},{"key":"31392_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).","journal-title":"Gigascience"},{"key":"31392_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol"},{"key":"31392_CR51","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41588-021-00924-w","volume":"53","author":"K Nurlan","year":"2021","unstructured":"Nurlan, K. et al. A compendium of uniformly processed human gene expression and splicing quantitative trait loci. Nat. Genet. 53, 1290\u20131299 (2021).","journal-title":"Nat. Genet."},{"key":"31392_CR52","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx Consortium.","year":"2020","unstructured":"The GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science 369, 1318\u20131330 (2020).","journal-title":"Science"},{"key":"31392_CR53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41588-019-0351-9","volume":"51","author":"R Ratnapriya","year":"2019","unstructured":"Ratnapriya, R. et al. Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration. Nat. Genet. 51, 606\u2013610 (2019).","journal-title":"Nat. Genet."},{"key":"31392_CR54","doi-asserted-by":"publisher","first-page":"eaba7612","DOI":"10.1126\/science.aba7612","volume":"370","author":"S Domcke","year":"2020","unstructured":"Domcke, S. et al. A human cell atlas of fetal chromatin accessibility. Science 370, eaba7612 (2020).","journal-title":"Science"},{"key":"31392_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1141-7","volume":"18","author":"KJ van der Velde","year":"2017","unstructured":"van der Velde, K. J. et al. GAVIN: Gene-Aware Variant INterpretation for medical sequencing. Genome Biol. 18, 1\u201310 (2017).","journal-title":"Genome Biol."},{"key":"31392_CR56","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ng1337","volume":"36","author":"J Marchini","year":"2004","unstructured":"Marchini, J., Cardon, L. R., Phillips, M. S. & Donnelly, P. The effects of human population structure on large genetic association studies. Nat. Genet. 36, 512\u2013517 (2004).","journal-title":"Nat. Genet."},{"key":"31392_CR57","doi-asserted-by":"publisher","first-page":"e025077","DOI":"10.1136\/bmjopen-2018-025077","volume":"9","author":"SYL Chua","year":"2019","unstructured":"Chua, S. Y. L. et al. Cohort profile: design and methods in the eye and vision consortium of UK Biobank. BMJ Open 9, e025077 (2019).","journal-title":"BMJ Open"},{"key":"31392_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.preteyeres.2007.07.005","volume":"27","author":"W Drexler","year":"2008","unstructured":"Drexler, W. & Fujimoto, J. G. State-of-the-art retinal optical coherence tomography. Prog. Retin. Eye Res. 27, 45\u201388 (2008).","journal-title":"Prog. Retin. Eye Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31392-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31392-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:09:25Z","timestamp":1669295365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31392-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31392"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31392-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.11.01.21265733","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.B. is a paid consultant and equity holder of Oxford Nanopore, a paid consultant to Dovetail, and a non-executive director of Genomics England, a limited company wholly owned by the UK Department of Health and Social Care. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3939"}}